Prothena | Les Charges D'Exploitation

Operating Expenses Changement Date
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Agios Pharmaceuticals USD 113.38M 5.08M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amgen USD 6.93B 2.11B 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Intra Cellular Therapies USD 166.2M 10.31M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Prothena Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.